Evidence map›Paper›PMID 27838878›Full record

ArticleJournal of applied genetics2017

Gene-environment interactions between ERCC2, ERCC3, XRCC1 and cadmium exposure in nasal polyposis disease.

Rim Khlifi, Pablo Olmedo, Fernando Gil, Boutheina Hammami, Amel Hamza-Chaffai, Ahmed Rebai

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of applied genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Rim KhlifiUnit of Marine and Environmental Toxicology, UR 09-03, Institut Préparatoire aux Etudes d'Ingénieur de Sfax (IPEIS), Sfax, Tunisia. rimkhlifi@yahoo.fr.
Pablo OlmedoDepartment of Legal Medicine and Toxicology, University of Granada, Granada, Spain.
Fernando GilDepartment of Legal Medicine and Toxicology, University of Granada, Granada, Spain.
Boutheina HammamiDepartment of Otorhinolaryngology, Habib Bourguiba Hospital, Sfax, Tunisia.
Amel Hamza-ChaffaiUnit of Marine and Environmental Toxicology, UR 09-03, Institut Préparatoire aux Etudes d'Ingénieur de Sfax (IPEIS), Sfax, Tunisia.
Ahmed RebaiLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, Sfax, Tunisia.
Institut Préparatoire aux Études d'Ingénieurs de Monastir · TNUniversidad de Granada · ESCentre of Biotechnology of Sfax · TNHopital Universitaire Habib Bourguiba · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene-environment interactions have long been known to play an important role in complex disease aetiology, such as nasal polyposis (NP). The present study supports the concept that DNA repair gene polymorphisms play critical roles in modifying individual susceptibility to environmental diseases. In fact, we investigated the role of polymorphisms in DNA repair genes and cadmium as risk factors for Tunisian patients with NP. To the best of our knowledge, this is the first report on the impact of combined effects of cadmium and ERCC3 7122 A>G (rs4150407), ERCC2 Lys751Gln (rs13181) and XRCC1 Arg399Gln (rs25487) genes in the susceptibility to NP disease. Significant associations between the risk of developing NP disease and ERCC2 [odds ratio (OR) = 2.0, 95 % confidence interval (CI) = 1.1-3.7, p = 0.023] and ERCC3 (OR = 2.2, 95 % CI = 1.2-4.1, p = 0.013) genotypes polymorphisms were observed. Blood concentrations of Cd in NP patients (2.2 μg/L) were significantly higher than those of controls (0.5 μg/L). A significant interaction between ERCC3 (7122 A>G) polymorphism and blood-Cd levels (for the median of blood-Cd levels: OR = 3.8, 95 % CI = 1.3-10.8, p = 0.014 and for the 75th percentiles of blood-Cd levels: OR = 2.7, 95 % CI = 1.1-7.2, p = 0.041) was found in association with the risk of NP disease. In addition, when we stratified ERCC2, ERCC3 and XRCC1 polymorphism genotypes by the median and 75th percentiles of blood-Cd levels, we found also significant interactions between ERCC2 (Lys751Gln) and ERCC3 (7122 A>G) genotypes polymorphism and this metal in association with NP disease. However, no interaction was found between XRCC1 (Arg399Gln) polymorphism genotypes and Cd in association with NP disease.

Indexed as

Gene-Environment InteractionAdultCadmiumCase-Control StudiesDNA-Binding ProteinsDNA HelicasesDNA RepairFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedNasal PolypsPolymorphism, GeneticRisk FactorsCadmiumDNA-Binding ProteinsDNA HelicasesERCC2 protein, humanXeroderma Pigmentosum Group D ProteinXPBC-ERCC-3 proteinX-ray Repair Cross Complementing Protein 1XRCC1 protein, humanCadmiumNasal polyposisPolymorphismsXPB/ERCC3 and XRCC1XPD/ERCC2

Identifiers

PMID27838878
OpenAlexW2554887827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.